{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T03:10:20Z","timestamp":1779160220096,"version":"3.51.4"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circ: Genomic and Precision Medicine"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND:<\/jats:title>\n            <jats:p>No disease-specific therapy currently exists for arrhythmogenic right ventricular cardiomyopathy (ARVC), a progressive cardiogenetic condition conferring elevated risk for ventricular arrhythmias, heart failure, and sudden cardiac death. Emerging gene therapies have the potential to fill this gap. However, little is known about how adults with ARVC, or any other inherited cardiomyopathy or arrhythmia syndrome, appraise the risks and benefits of gene therapy research and which considerations may influence their decisions about clinical trial participation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>Twenty adults with clinically diagnosed and gene-positive ARVC participated in semi-structured interviews that explored perceptions of gene therapy and hypothetical decision-making for gene therapy clinical trial participation. Interview transcripts were qualitatively coded and analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Participants expressed enthusiasm for gene therapy with varied levels of personal interest in trial participation. Although clinical severity appeared to be associated with an elevated interest in early trial participation, participants anticipated weighing both personal and trial-specific factors including life stage, trial stage, risks, benefits, participation burden, study leadership, and anticipated cost of future gene therapy. Adaptation to living with ARVC and involvement in the ARVC patient community were also relevant to decision-making about trial participation. Potential ethical concerns included unquestioning trust in clinical teams collaborating on industry-led trials and vulnerability of those recently diagnosed or with high perceived severity of ARVC symptoms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Several characteristics of the individual and trial warrant consideration during the informed consent process. Insights from this study may affect trial planning and communication with participants who have inherited cardiac conditions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/circgen.124.004759","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T10:00:26Z","timestamp":1732874426000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Patient Perceptions of Emerging Gene Therapies for Arrhythmogenic Right Ventricular Cardiomyopathy"],"prefix":"10.1161","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0419-049X","authenticated-orcid":true,"given":"Emma M.","family":"Schopp","sequence":"first","affiliation":[{"name":"Center for Precision Health Research, National Human Genome Research Institute, Bethesda, MD (E.M.S., A.T.)."},{"name":"Department of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (E.M.S.)."},{"name":"Military Cardiovascular Outcomes Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD (E.M.S.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6948-833X","authenticated-orcid":true,"given":"Leonore","family":"Okwara","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Johns Hopkins University, Baltimore, MD (L.O., C.T., B.M., A.S.B., H.C., C.A.J.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crystal","family":"Tichnell","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Johns Hopkins University, Baltimore, MD (L.O., C.T., B.M., A.S.B., H.C., C.A.J.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8065-7445","authenticated-orcid":true,"given":"Amy","family":"Turriff","sequence":"additional","affiliation":[{"name":"Center for Precision Health Research, National Human Genome Research Institute, Bethesda, MD (E.M.S., A.T.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittney","family":"Murray","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Johns Hopkins University, Baltimore, MD (L.O., C.T., B.M., A.S.B., H.C., C.A.J.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5275-8049","authenticated-orcid":true,"given":"Andreas S.","family":"Barth","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Johns Hopkins University, Baltimore, MD (L.O., C.T., B.M., A.S.B., H.C., C.A.J.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9262-9433","authenticated-orcid":true,"given":"Hugh","family":"Calkins","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Johns Hopkins University, Baltimore, MD (L.O., C.T., B.M., A.S.B., H.C., C.A.J.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1132-2411","authenticated-orcid":true,"given":"Leila","family":"Jamal","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute (L.J.)."},{"name":"Department of Bioethics, NIH, Bethesda, MD (L.J.)."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8040-4600","authenticated-orcid":true,"given":"Cynthia A.","family":"James","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Johns Hopkins University, Baltimore, MD (L.O., C.T., B.M., A.S.B., H.C., C.A.J.)."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","unstructured":"Tenaya Therapeutics. Tenaya Therapeutics doses first patient in the MyPeak-1\u2122 Phase 1b clinical trial of TN-201 for the treatment of MYBPC3-associated hypertrophic cardiomyopathy. Globe Newswire. October 5 2023."},{"key":"e_1_3_3_3_2","unstructured":"Tenaya Therapeutics. Study of safety and tolerability of TN-201 in adults with symptomatic MYBPC3 mutation-associated HCM (MyPEAK-1). ClinicalTrials.gov Identifier: NCT05836259. Accessed April 21 2024. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05836259"},{"key":"e_1_3_3_4_2","unstructured":"Rocket Pharmaceuticals Inc. A multi-center open label gene therapy study of RP-A501 in male patients with Danon disease. Clinicaltrials.gov identifier: NCT06092034. Accessed April 21 2024. https:\/\/clinicaltrials.gov\/study\/NCT06092034"},{"key":"e_1_3_3_5_2","unstructured":"Rocket Pharmaceuticals Inc. A phase 1 dose escalation trial of RP-A601 in subjects with PKP2 variant-mediated arrhythmogenic cardiomyopathy (PKP2-ACM). ClinicalTrials.gov identifier: NCT05885412. Accessed April 21 2024. https:\/\/clinicaltrials.gov\/study\/NCT05885412"},{"key":"e_1_3_3_6_2","unstructured":"Lexeo Therapeutics. Gene therapy for ACM due to a PKP2 pathogenic variant. ClinicalTrials.gov identifier: NCT06109181. Accessed April 21 2024. https:\/\/clinicaltrials.gov\/study\/NCT06109181"},{"key":"e_1_3_3_7_2","unstructured":"Tenaya Therapeutics. Open-label dose escalation study of safety and preliminary efficacy of TN-401 in adults with PKP2 mutation-associated ARVC (RIDGE-1). ClinicalTrials.gov identifier: NCT06228924. Accessed April 21 2024. https:\/\/clinicaltrials.gov\/study\/NCT06228924"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.120.051836"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.122.003719"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.038514"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa107"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2414"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccep.2023.04.006"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2023.11.024"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.120.003273"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-021-01233-7"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.2021.35.S1.03193"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/s44161-023-00378-9"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.123.004305"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-306647"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.2141"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01333-6"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa084"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa821"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20096-1"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-021-01763-z"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-022-03598-3"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2019.03.009"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2020.03.014"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2015.11.006"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1089\/AID.2019.0021"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0027-9684(15)30766-5"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2022.100855"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1080\/23294515.2020.1818876"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14401"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.017944"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.111.960898"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.055890"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1159\/000435887"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14572"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-022-00364-z"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213649"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.146.suppl_1.13599"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1136\/jme.2010.038943"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7139.1230"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.7208\/chicago\/9780226817729.001.0001"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.840827"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2021.04.028"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1177\/1744987120927206"},{"key":"e_1_3_3_50_2","unstructured":"ASGCT Patient Education. American society of gene & cell therapy. Accessed February 2023. https:\/\/patienteducation.asgct.org\/. 2023."}],"container-title":["Circulation: Genomic and Precision Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCGEN.124.004759","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T21:13:13Z","timestamp":1748553193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCGEN.124.004759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1161\/CIRCGEN.124.004759"],"URL":"https:\/\/doi.org\/10.1161\/circgen.124.004759","relation":{},"ISSN":["2574-8300"],"issn-type":[{"value":"2574-8300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"2024-05-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}